Herbal Nanoformulations for Diabetes: Mechanisms, Formulations, and Clinical Impact

Overview

Journal Curr Diabetes Rev

Publisher Bentham Science Publishers

Specialty Endocrinology

Date 2024 Mar 19

PMID 38500279

Authors

Sunita

Rahul Kaushik

Krishan Kumar Verma

Rehana Parveen

Affiliations

Soon will be listed here.

Abstract

Background: Diabetes mellitus remains a global health challenge, demanding innovative therapeutic strategies. Herbal remedies have garnered attention for their potential in diabetes management, and recent advancements in nanotechnology have enabled the development of herbal nanoformulations with enhanced efficacy and bioavailability.

Objective: This review aimed to comprehensively analyze the mechanisms, formulations, and clinical impact of herbal nanoformulations in managing diabetes mellitus.

Method: A systematic literature search was conducted to identify relevant studies exploring the mechanisms of action, various formulations, and clinical outcomes of herbal nanoformulations in diabetes management.

Result: Herbal nanoformulations exert their anti-diabetic effects through multiple mechanisms, including enhanced bioavailability, improved tissue targeting, and potentiation of insulin signaling pathways. Various herbal ingredients, such as bitter melon, fenugreek, and Gymnema sylvestre, have been encapsulated into nanocarriers, like liposomes, polymeric nanoparticles, and solid lipid nanoparticles, to enhance their therapeutic potential. Clinical studies have demonstrated promising results, showing improvements in glycemic control, lipid profile, and antioxidant status with minimal adverse effects.

Conclusion: Herbal nanoformulations represent a promising avenue for the management of diabetes mellitus, offering improved therapeutic outcomes compared to conventional herbal preparations. Further research is warranted to optimize formulation strategies, elucidate long-term safety profiles, and explore the potential synergistic effects of herbal nanoformulations in combination therapies for diabetes management.

References

DiSanto R, Subramanian V, Gu Z . Recent advances in nanotechnology for diabetes treatment. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015; 7(4):548-64. PMC: 4478103. DOI: 10.1002/wnan.1329. View

Marella S, Tollamadugu N . Nanotechnological approaches for the development of herbal drugs in treatment of diabetes mellitus - a critical review. IET Nanobiotechnol. 2018; 12(5):549-556. PMC: 8676124. DOI: 10.1049/iet-nbt.2017.0242. View

Ruan S, Guo X, Ren Y, Cao G, Xing H, Zhang X . Nanomedicines based on trace elements for intervention of diabetes mellitus. Biomed Pharmacother. 2023; 168:115684. DOI: 10.1016/j.biopha.2023.115684. View

Vidal Bonifacio B, da Silva P, Dos Santos Ramos M, Negri K, Bauab T, Chorilli M . Nanotechnology-based drug delivery systems and herbal medicines: a review. Int J Nanomedicine. 2013; 9:1-15. PMC: 3862741. DOI: 10.2147/IJN.S52634. View

Ansari S, Islam F, Sameem M . Influence of nanotechnology on herbal drugs: A Review. J Adv Pharm Technol Res. 2012; 3(3):142-6. PMC: 3459443. DOI: 10.4103/2231-4040.101006. View

Tenchov R, Bird R, Curtze A, Zhou Q . Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement. ACS Nano. 2021; 15(11):16982-17015. DOI: 10.1021/acsnano.1c04996. View

Taghipour Y, Hajialyani M, Naseri R, Hesari M, Mohammadi P, Stefanucci A . Nanoformulations of natural products for management of metabolic syndrome. Int J Nanomedicine. 2019; 14:5303-5321. PMC: 6642644. DOI: 10.2147/IJN.S213831. View

Rahman M, Dhar P, Sumaia , Anika F, Ahmed L, Islam M . Exploring the plant-derived bioactive substances as antidiabetic agent: An extensive review. Biomed Pharmacother. 2022; 152:113217. DOI: 10.1016/j.biopha.2022.113217. View

Farihi A, Bouhrim M, Chigr F, Elbouzidi A, Bencheikh N, Zrouri H . Exploring Medicinal Herbs' Therapeutic Potential and Molecular Docking Analysis for Compounds as Potential Inhibitors of Human Acetylcholinesterase in Alzheimer's Disease Treatment. Medicina (Kaunas). 2023; 59(10). PMC: 10608285. DOI: 10.3390/medicina59101812. View

10.

Zhao Q, Luan X, Zheng M, Tian X, Zhao J, Zhang W . Synergistic Mechanisms of Constituents in Herbal Extracts during Intestinal Absorption: Focus on Natural Occurring Nanoparticles. Pharmaceutics. 2020; 12(2). PMC: 7076514. DOI: 10.3390/pharmaceutics12020128. View

11.

Guo M, Qin S, Wang S, Sun M, Yang H, Wang X . Herbal Medicine Nanocrystals: A Potential Novel Therapeutic Strategy. Molecules. 2023; 28(17). PMC: 10489021. DOI: 10.3390/molecules28176370. View

12.

Kesarwani K, Gupta R, Mukerjee A . Bioavailability enhancers of herbal origin: an overview. Asian Pac J Trop Biomed. 2013; 3(4):253-66. PMC: 3634921. DOI: 10.1016/S2221-1691(13)60060-X. View

13.

Date A, Hanes J, Ensign L . Nanoparticles for oral delivery: Design, evaluation and state-of-the-art. J Control Release. 2016; 240:504-526. PMC: 5064878. DOI: 10.1016/j.jconrel.2016.06.016. View

14.

Veselov V, Nosyrev A, Jicsinszky L, Alyautdin R, Cravotto G . Targeted Delivery Methods for Anticancer Drugs. Cancers (Basel). 2022; 14(3). PMC: 8833699. DOI: 10.3390/cancers14030622. View

15.

Ibrahim M, Garcia-Contreras L . Mechanisms of absorption and elimination of drugs administered by inhalation. Ther Deliv. 2013; 4(8):1027-45. DOI: 10.4155/tde.13.67. View

16.

Wang L, Hu C, Shao L . The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int J Nanomedicine. 2017; 12:1227-1249. PMC: 5317269. DOI: 10.2147/IJN.S121956. View

17.

Majumder J, Taratula O, Minko T . Nanocarrier-based systems for targeted and site specific therapeutic delivery. Adv Drug Deliv Rev. 2019; 144:57-77. PMC: 6748653. DOI: 10.1016/j.addr.2019.07.010. View

18.

Patra J, Das G, Fraceto L, Campos E, Del Pilar Rodriguez-Torres M, Acosta-Torres L . Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018; 16(1):71. PMC: 6145203. DOI: 10.1186/s12951-018-0392-8. View

19.

Yu B, Tai H, Xue W, Lee L, Lee R . Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol. 2010; 27(7):286-98. PMC: 3789246. DOI: 10.3109/09687688.2010.521200. View

20.

Han H, Koo S, Choi K . Emerging nanoformulation strategies for phytocompounds and applications from drug delivery to phototherapy to imaging. Bioact Mater. 2022; 14:182-205. PMC: 8892098. DOI: 10.1016/j.bioactmat.2021.11.027. View